Abstract

 BACKGROUND:
Laparoscopic sleeve gastrectomy LSG is known to be a highly effective treatment for morbid obesity
and many related conditions including type 2 diabetes mellitus (T2DM) and the metabolic syndrome.
OBJECTIVE:
To assess the effectiveness of (LSG) on glucose homeostasis in morbidly obese diabetic patients and
it shows early experience of metabolic surgery.
METHODS:
Prospective clinical case series study conducted in Al-Jumhoori Teaching Hospital and involved 20
patients (17 females and 3 males); their age (22-54 average 37 years) underwent LSG and the level
of glucose evaluated at different times by measuring fasting blood glucose level, glycosylated
hemoglobin (HbA1C).
RESULTS:
The initial body weight 70-142(110Kg); BMI 31.8-53.9 (45.16Kg/m2); two patients with diabetes
mellitus and BMI less than 35Kg/m2 involved.
The mean level of fasting blood glucose assessed and found to be (202,165,130,107,96 mg/dl) in
preoperative ,one-day postoperative,10 days, three and six-months interval; while the level of
HbA1C were( 10.2,9,7.2,6.1) in the preoperative ,10 days,3 and 6 months interval respectively.
CONCLUSION:
LSG is an effective procedure to decrease weight for morbid obesity and it resolve T2DM in 90%
while improvement of T2DM occurred in 10 % so LSG is an effective procedure to treat T2DM
and the level of glucose declined significantly started from early postoperative and continued till 6
months.